BMR Pengajuan SEC - Beamr Imaging Ltd.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

1289236

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Beamr Imaging Ltd.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

February 10, 2016	SC 13G/A	BMR / Biomed Realty Trust / VANGUARD GROUP INC Passive Investment biomedrealtytrustinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12 )* Name of issuer: BioMed Realty Trust Inc Title of Class of Securities: REIT CUSIP Number: 09063H107 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate bo
February 9, 2016	SC 13G/A	BMR / Biomed Realty Trust / VANGUARD SPECIALIZED FUNDS Passive Investment biomendrealtytrustamd6.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:6 )* Name of issuer: BioMed Realty Trust Inc Title of Class of Securities: REIT CUSIP Number: 09063H107 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate bo
February 8, 2016	15-12B	Biomed Realty Trust 15-12B 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number: 1-32261 BIOMED REALTY TRUST, INC. (BRE Edison L.P. as successor by m
January 29, 2016	EX-99.25	EX-99.25 NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on February 9, 2016, pursuant to the provisions of Rule 12d2-2 (a).
January 27, 2016	POSASR	Biomed Realty Trust POSASR POSASR As filed with the Securities and Exchange Commission on January 27, 2016 Registration No.
January 27, 2016	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2016 BioMed Realty Trust, Inc. (BRE Edison L.P. as successor by merger to BioMed Realty Trust, Inc.) BioMed Realty, L.P. (Exact name of registrant as specified in
January 27, 2016	S-8 POS	Biomed Realty Trust S-8 POS S-8 POS As filed with the Securities and Exchange Commission on January 27, 2016 Registration No.
January 27, 2016	EX-99.1	BLACKSTONE COMPLETES ACQUISITION OF BIOMED REALTY TRUST EX-99.1 Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BLACKSTONE COMPLETES ACQUISITION OF BIOMED REALTY TRUST SAN DIEGO, Calif. ? January 27, 2016 ? BioMed Realty Trust, Inc. (NYSE: BMR) (the ?Company?) announced today the completion of its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L
January 27, 2016	S-8 POS	Biomed Realty Trust S-8 POS S-8 POS 1 d48940ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 27, 2016 Registration No. 333-193866 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BioMed Realty Trust, Inc. (BRE Edison L.P. as successor by merger to BioMed Realty Trust, Inc
January 27, 2016	POSASR	Biomed Realty Trust POSASR POSASR As filed with the Securities and Exchange Commission on January 27, 2016 Registration No.
January 27, 2016	POSASR	Biomed Realty Trust POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 Post-Effective Amendment No. 1 To Form S-3 As filed with the Securities and Exchange Commission on January 27, 2016 Registration No. 333-206650 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 To Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BioMed Realty Trust, Inc. (BRE Edison L.P. as successor by merger to BioMed Realty Tr
January 27, 2016	S-8 POS	Biomed Realty Trust S-8 POS S-8 POS As filed with the Securities and Exchange Commission on January 27, 2016 Registration No.
January 21, 2016	8-K	Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2016 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 20-1142292 (BioMed Realty Trust
January 21, 2016	EX-99.1	BIOMED REALTY TRUST STOCKHOLDERS APPROVE ACQUISITION BY BLACKSTONE EX-99.1 Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST STOCKHOLDERS APPROVE ACQUISITION BY BLACKSTONE SAN DIEGO, Calif. ? January 21, 2016 ? BioMed Realty Trust, Inc. (NYSE: BMR) announced that its common stockholders approved the acquisition of BioMed Realty by affiliates of Blackstone Real Estate Partners V
January 19, 2016	SC 13G	ZSAN / Zosano Pharma Corporation / BioMed Realty Trust Inc - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. )* Zosano Pharma Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 98979H103 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to des
January 19, 2016	EX-99.1	JOINT FILING AGREEMENT EX-99.1 EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the common stock of Zosano Pharma Corporation, and further agree that this Agreement shall be included as an exhi
January 6, 2016	8-K	Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2016 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (B
January 6, 2016	DEFA14A	Biomed Realty Trust DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive
January 4, 2016	EX-10.3	EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT EX-10.3 Exhibit 10.3 EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT This Equity Award Acceleration and Share Restriction Agreement (this ?Agreement?) is made and entered into as of December 31, 2015 (the ?Effective Date?), by and between BioMed Realty Trust, Inc., a Maryland corporation (the ?Company?), and Greg N. Lubushkin (?Holder?). R E C I T A L S A. WHEREAS, Holder currently holds
January 4, 2016	EX-10.9	Page 2 EX-10.9 Exhibit 10.9 December [ ], 2015 [Employee Name] BioMed Realty Trust, Inc. 17190 Bernardo Center Drive San Diego, California 92128 RE: Section 280G Treatment BioMed Realty Trust, Inc. and BioMed Realty, L.P. (together, the ?Company?) and [Employee Name] (the ?Employee?) hereby agree to the following: 1. Section 280G Treatment. In the event that any payment or benefit received or to be recei
January 4, 2016	EX-10.2	EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT EX-10.2 Exhibit 10.2 EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT This Equity Award Acceleration and Share Restriction Agreement (this ?Agreement?) is made and entered into as of December 31, 2015 (the ?Effective Date?), by and between BioMed Realty Trust, Inc., a Maryland corporation (the ?Company?), and Alan D. Gold (?Holder?). R E C I T A L S A. WHEREAS, Holder currently holds the
January 4, 2016	EX-10.10	BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. LTIP UNIT AWARD CANCELLATION AGREEMENT EX-10.10 Exhibit 10.10 BIOMED REALTY TRUST, INC. AND BIOMED REALTY, L.P. LTIP UNIT AWARD CANCELLATION AGREEMENT This LTIP Unit Award Cancellation Agreement (this ?Agreement?), is executed and made effective as of December 30, 2015, by and between BioMed Realty Trust, Inc., a Maryland corporation (the ?Corporation?), BioMed Realty, L.P., a Maryland limited partnership (the ?Partnership,? and, toget
January 4, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2015 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioM
January 4, 2016	EX-10.7	EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT EX-10.7 Exhibit 10.7 EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT This Equity Award Acceleration and Share Restriction Agreement (this ?Agreement?) is made and entered into as of December 31, 2015 (the ?Effective Date?), by and between BioMed Realty Trust, Inc., a Maryland corporation (the ?Company?), and Jonathan P. Klassen (?Holder?). R E C I T A L S A. WHEREAS, Holder currently hol
January 4, 2016	EX-10.4	EQUITY AWARD ACCELERATION AGREEMENT EX-10.4 Exhibit 10.4 EQUITY AWARD ACCELERATION AGREEMENT This Equity Award Acceleration Agreement (this ?Agreement?) is made and entered into as of December 31, 2015 (the ?Effective Date?), by and between BioMed Realty Trust, Inc., a Maryland corporation (the ?Company?), and Gary A. Kreitzer (?Holder?). R E C I T A L S A. WHEREAS, Holder currently holds the unvested restricted stock awards describ
January 4, 2016	EX-10.8	EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT EX-10.8 Exhibit 10.8 EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT This Equity Award Acceleration and Share Restriction Agreement (this ?Agreement?) is made and entered into as of December 31, 2015 (the ?Effective Date?), by and between BioMed Realty Trust, Inc., a Maryland corporation (the ?Company?), and Karen A. Sztraicher (?Holder?). R E C I T A L S A. WHEREAS, Holder currently hol
January 4, 2016	EX-10.5	EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT EX-10.5 Exhibit 10.5 EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT This Equity Award Acceleration and Share Restriction Agreement (this ?Agreement?) is made and entered into as of December 31, 2015 (the ?Effective Date?), by and between BioMed Realty Trust, Inc., a Maryland corporation (the ?Company?), and James R. Berens (?Holder?). R E C I T A L S A. WHEREAS, Holder currently holds t
January 4, 2016	EX-10.6	EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT EX-10.6 Exhibit 10.6 EQUITY AWARD ACCELERATION AND SHARE RESTRICTION AGREEMENT This Equity Award Acceleration and Share Restriction Agreement (this ?Agreement?) is made and entered into as of December 31, 2015 (the ?Effective Date?), by and between BioMed Realty Trust, Inc., a Maryland corporation (the ?Company?), and John P. Bonanno (?Holder?). R E C I T A L S A. WHEREAS, Holder currently holds t
January 4, 2016	EX-10.1	BIOMED REALTY TRUST, INC. RESTRICTED CASH AWARD GRANT NOTICE AND RESTRICTED CASH AWARD AGREEMENT EX-10.1 Exhibit 10.1 Executive Version BIOMED REALTY TRUST, INC. RESTRICTED CASH AWARD GRANT NOTICE AND RESTRICTED CASH AWARD AGREEMENT BioMed Realty Trust, Inc., a Maryland corporation (the Company), hereby grants to the individual listed below (Participant), a restricted cash award with an aggregate value set forth below. This award (this Award) is subject to all of the terms and condition
December 8, 2015	DEFM14A	Biomed Realty Trust DEFM14A DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.
November 16, 2015	PREM14A	Biomed Realty Trust PREM14A PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.
November 5, 2015	10-Q	Biomed Realty Trust 10-Q (Quarterly Report) 10-Q 1 bmr-2015930x10q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact nam
November 5, 2015	EX-99.2	Supplemental Operating and Financial Data : September 30, 2015 TABLE OF CONTENTS SEPTEMBER 30, 2015 Page Page Third Quarter Highlights 3 Debt Analysis 20 Investor Information 4 Debt Maturities 21 Equity Research Coverage 5 Market Summary 22 Financial EX-99.2 Exhibit 99.2 Supplemental Operating and Financial Data : September 30, 2015 BioMed Realty Trust, Inc. Investor Relations 17190 Bernardo Center Drive Corporate Communications Contact: San Diego, CA 92128 Rick Howe t 858.485.9840 f 858.485.9843 Senior Director, Corporate Communications biomedrealty.com [email protected] TABLE OF CONTENTS SEPTEMBER 30, 2015 Page Page Third Quarter
November 5, 2015	EX-99.1	BIOMED REALTY TRUST REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS Q3 Gross Leasing Volume of 1.3 Million SF Drives 734,000 SF of Positive Net Absorption during the Quarter EX-99.1 Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS Q3 Gross Leasing Volume of 1.3 Million SF Drives 734,000 SF of Positive Net Absorption during the Quarter SAN DIEGO, Calif. ? November 5, 2015 ? BioMed Realty Trust, Inc. (NYSE: BMR), investing in the highest q
November 5, 2015	DEFA14A	Biomed Realty Trust FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2015 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (
November 5, 2015	EX-99.2	Supplemental Operating and Financial Data : September 30, 2015 TABLE OF CONTENTS SEPTEMBER 30, 2015 Page Page Third Quarter Highlights 3 Debt Analysis 20 Investor Information 4 Debt Maturities 21 Equity Research Coverage 5 Market Summary 22 Financial EX-99.2 Exhibit 99.2 Supplemental Operating and Financial Data : September 30, 2015 BioMed Realty Trust, Inc. Investor Relations 17190 Bernardo Center Drive Corporate Communications Contact: San Diego, CA 92128 Rick Howe t 858.485.9840 f 858.485.9843 Senior Director, Corporate Communications biomedrealty.com [email protected] TABLE OF CONTENTS SEPTEMBER 30, 2015 Page Page Third Quarter
November 5, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2015 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (
November 5, 2015	EX-10.1	AMENDMENT NUMBER 1 TO THE BIOMED REALTY TRUST, INC. SEVERANCE PLAN AMENDMENT NUMBER 1 TO THE BIOMED REALTY TRUST, INC. SEVERANCE PLAN WHEREAS, BioMed Realty Trust, Inc. (the “Company”), maintains the BioMed Realty Trust Inc. Severance Plan effective August 25, 2010 (the “Plan”) for the benefit of certain eligible employees; and WHEREAS, the Plan provides for severance benefits for eligible employees who experience an Involuntary Termination (as defined in the Pla
November 5, 2015	EX-99.1	BIOMED REALTY TRUST REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS Q3 Gross Leasing Volume of 1.3 Million SF Drives 734,000 SF of Positive Net Absorption during the Quarter EX-99.1 Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS Q3 Gross Leasing Volume of 1.3 Million SF Drives 734,000 SF of Positive Net Absorption during the Quarter SAN DIEGO, Calif. ? November 5, 2015 ? BioMed Realty Trust, Inc. (NYSE: BMR), investing in the highest q
October 26, 2015	DEFA14A	Biomed Realty Trust DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive
October 8, 2015	8-K	Biomed Realty Trust FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2015 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (B
October 8, 2015	DEFA14A	Biomed Realty Trust FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2015 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Rea
October 8, 2015	EX-2.1	AGREEMENT AND PLAN OF MERGER DATED AS OF OCTOBER 7, 2015 BY AND AMONG BIOMED REALTY TRUST, INC., BIOMED REALTY, L.P., BRE EDISON HOLDINGS L.P., BRE EDISON L.P. BRE EDISON ACQUISITION L.P. ARTICLE I.THE MERGERS 2 Section 1.1 The Mergers 2 Section 1.2 EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER DATED AS OF OCTOBER 7, 2015 BY AND AMONG BIOMED REALTY TRUST, INC., BIOMED REALTY, L.P., BRE EDISON HOLDINGS L.P., BRE EDISON L.P. AND BRE EDISON ACQUISITION L.P. ARTICLE I.THE MERGERS 2 Section 1.1 The Mergers 2 Section 1.2 Governing Documents 3 Section 1.3 Directors, Officers and General Partner and Limited Partner of the Survivin
October 8, 2015	EX-99.1	BIOMED REALTY ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY BLACKSTONE FOR $23.75 PER SHARE IN $8 BILLION TRANSACTION EX-99.1 Exhibit 99.1 BIOMED REALTY ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY BLACKSTONE FOR $23.75 PER SHARE IN $8 BILLION TRANSACTION SAN DIEGO, Calif. ? October 8, 2015 ? BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has entered into a definitive agreement with affiliates of Blackstone Real Estate Partners VIII, under which Blackstone will acquire all outstanding shares
October 8, 2015	EX-3.1	BIOMED REALTY TRUST, INC. FOURTH AMENDED AND RESTATED BYLAWS ARTICLE I EX-3.1 Exhibit 3.1 BIOMED REALTY TRUST, INC. FOURTH AMENDED AND RESTATED BYLAWS ARTICLE I OFFICES Section 1. PRINCIPAL OFFICE. The principal office of the Corporation in the State of Maryland shall be located at such place as the Board of Directors may designate. Section 2. ADDITIONAL OFFICES. The Corporation may have additional offices, including a principal executive office, at such places as th
October 8, 2015	EX-99.1	BIOMED REALTY ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY BLACKSTONE FOR $23.75 PER SHARE IN $8 BILLION TRANSACTION EX-99.1 Exhibit 99.1 BIOMED REALTY ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY BLACKSTONE FOR $23.75 PER SHARE IN $8 BILLION TRANSACTION SAN DIEGO, Calif. ? October 8, 2015 ? BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has entered into a definitive agreement with affiliates of Blackstone Real Estate Partners VIII, under which Blackstone will acquire all outstanding shares
October 8, 2015	EX-3.1	BIOMED REALTY TRUST, INC. FOURTH AMENDED AND RESTATED BYLAWS ARTICLE I EX-3.1 Exhibit 3.1 BIOMED REALTY TRUST, INC. FOURTH AMENDED AND RESTATED BYLAWS ARTICLE I OFFICES Section 1. PRINCIPAL OFFICE. The principal office of the Corporation in the State of Maryland shall be located at such place as the Board of Directors may designate. Section 2. ADDITIONAL OFFICES. The Corporation may have additional offices, including a principal executive office, at such places as th
October 8, 2015	EX-2.1	AGREEMENT AND PLAN OF MERGER DATED AS OF OCTOBER 7, 2015 BY AND AMONG BIOMED REALTY TRUST, INC., BIOMED REALTY, L.P., BRE EDISON HOLDINGS L.P., BRE EDISON L.P. BRE EDISON ACQUISITION L.P. ARTICLE I.THE MERGERS 2 Section 1.1 The Mergers 2 Section 1.2 EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER DATED AS OF OCTOBER 7, 2015 BY AND AMONG BIOMED REALTY TRUST, INC., BIOMED REALTY, L.P., BRE EDISON HOLDINGS L.P., BRE EDISON L.P. AND BRE EDISON ACQUISITION L.P. ARTICLE I.THE MERGERS 2 Section 1.1 The Mergers 2 Section 1.2 Governing Documents 3 Section 1.3 Directors, Officers and General Partner and Limited Partner of the Survivin
August 28, 2015	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2015 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commis
August 28, 2015	S-3ASR	Biomed Realty Trust S-3ASR S-3ASR 1 d39818ds3asr.htm S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 28, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact Name of Registrant as Specified in Its Charter) (Exact Name of Re
August 28, 2015	EX-12.1	BioMed Realty Trust, Inc. Statement of Computation of Ratios 6 Mo. Ended June 30, Year Ended December 31, 2015 2014 2013 2012 2011 2010 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidat EX-12.1 Exhibit 12.1 BioMed Realty Trust, Inc. Statement of Computation of Ratios 6 Mo. Ended June 30, Year Ended December 31, 2015 2014 2013 2012 2011 2010 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 58,064 $ 200,723 $ 48,114 $ 17,522 $ 44,729 $ 39,256 Amortization of interest capitalized 2,972 5,661 5,343 5
August 28, 2015	S-3ASR	Biomed Realty Trust S-3ASR S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 28, 2015 Registration No.
August 28, 2015	EX-1.1	BIOMED REALTY TRUST, INC. Shares of Common Stock (par value $0.01 per share) EQUITY DISTRIBUTION AGREEMENT EX-1.1 Exhibit 1.1 BIOMED REALTY TRUST, INC. $300,000,000 Shares of Common Stock (par value $0.01 per share) EQUITY DISTRIBUTION AGREEMENT Dated: August 28, 2015 Table of Contents Page SECTION 1. Description of Securities 1 SECTION 2. Placements 2 SECTION 3. Sale of Placement Securities by the Manager 3 SECTION 4. Suspension of Sales 3 SECTION 5. Representations and Warranties 4 SECTION 6. Sale an
August 28, 2015	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2015 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Rea
August 28, 2015	S-3ASR	Biomed Realty Trust S-3ASR S-3ASR 1 d34499ds3asr.htm S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 28, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BioMed Realty Trust, Inc. (Exact Name of Registrant as Specified in Its Charter) Maryland 20-1142292 (State or Other J
August 28, 2015	424B5	CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Proposed Maximum Aggregate Offering Price(1) Amount of Registration Fee(2) Common Stock, $0.01 par value per share $300,000,000 $23,636 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Statement No.
August 28, 2015	EX-3.1	BIOMED REALTY TRUST, INC. ARTICLES OF AMENDMENT EX-3.1 Exhibit 3.1 BIOMED REALTY TRUST, INC. ARTICLES OF AMENDMENT BioMed Realty Trust, Inc., a Maryland corporation (the ?Corporation?), hereby certifies to the State Department of Assessments and Taxation of Maryland that: FIRST: The charter of the Corporation (the ?Charter?) is hereby amended by deleting therefrom in its entirety the first two sentences of Section 5.1 of Article V and inserting
July 29, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Commission File Number: 1-32261 (Bi UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in its c
July 29, 2015	EX-99.2	Supplemental Operating and Financial Data : June 30, 2015 TABLE OF CONTENTS JUNE 30, 2015 Page Page Second Quarter Highlights 3 Debt Summary 20 Investor Information 4 Debt Analysis 21 * Equity Research Coverage 5 Debt Maturities 22 * Financial and Op EX-99.2 Exhibit 99.2 Supplemental Operating and Financial Data : June 30, 2015 BioMed Realty Trust, Inc. Investor Relations 17190 Bernardo Center Drive Corporate Communications Contact: San Diego, CA 92128 Rick Howe t 858.485.9840 f 858.485.9843 Senior Director, Corporate Communications biomedrealty.com [email protected] TABLE OF CONTENTS JUNE 30, 2015 Page Page Second Quarter Highligh
July 29, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2015 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commission F
July 29, 2015	EX-99.1	BIOMED REALTY TRUST REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS Company Reports FFO and Core FFO of $0.58 for Second Quarter Driven by Accelerating Cash Flows from Strong Leasing Momentum and Investment Returns EX-99.1 Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS Company Reports FFO and Core FFO of $0.58 for Second Quarter Driven by Accelerating Cash Flows from Strong Leasing Momentum and Investment Returns SAN DIEGO, Calif. ? July 28, 2015 ? BioMed Realty Trust, Inc.
May 29, 2015	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Material Impairments 8-K 1 d937311d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2015 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust,
May 29, 2015	EX-99.1	BIOMED REALTY TRUST SELLS KING OF PRUSSIA PROPERTY IN RADNOR TO PENN MEDICINE FOR $35 MILLION Company To Redeploy Capital Into Growing Core Innovation Markets EX-99.1 Exhibit 99.1 CONTACT: Jim Cullinan Vice President, Marketing (858) 753-8661 [email protected] BIOMED REALTY TRUST SELLS KING OF PRUSSIA PROPERTY IN RADNOR TO PENN MEDICINE FOR $35 MILLION Company To Redeploy Capital Into Growing Core Innovation Markets SAN DIEGO ? May 29, 2015 ? BioMed Realty Trust, Inc. (NYSE: BMR) announced today the completion of the sale of its property at
May 28, 2015	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2015 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commission Fi
May 15, 2015	DEFA14A	Biomed Realty Trust DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? De
April 29, 2015	EX-10.3	CHANGE IN CONTROL AND SEVERANCE AGREEMENT EXHIBIT 10.3 CHANGE IN CONTROL AND SEVERANCE AGREEMENT THIS CHANGE IN CONTROL AND SEVERANCE AGREEMENT (this ?Agreement?), effective as of August 28, 2013 (the ?Effective Date?), is entered into by and among BioMed Realty Trust, Inc., a Maryland corporation (the ?REIT?), BioMed Realty, L.P., a Maryland limited partnership (the ?Operating Partnership,? and together with the REIT, the ?Company?), and
April 29, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 Commission File Number: 1-32261 (B 10-Q 1 bmr-2015331x10q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of
April 29, 2015	EX-10.2	CHANGE IN CONTROL AND SEVERANCE AGREEMENT EXHIBIT 10.2 CHANGE IN CONTROL AND SEVERANCE AGREEMENT THIS CHANGE IN CONTROL AND SEVERANCE AGREEMENT (this “Agreement”), effective as of February 10, 2015 (the “Effective Date”), is entered into by and among BioMed Realty Trust, Inc., a Maryland corporation (the “REIT”), BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership,” and together with the REIT, the “Company”), a
April 29, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d917319d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2015 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of In
April 29, 2015	EX-99.1	BIOMED REALTY TRUST REPORTS FIRST QUARTER 2015 FINANCIAL RESULTS Strong Gross Leasing Continues with 780,800 Square Feet During the Quarter EX-99.1 2 d917319dex991.htm EX-99.1 Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS FIRST QUARTER 2015 FINANCIAL RESULTS Strong Gross Leasing Continues with 780,800 Square Feet During the Quarter SAN DIEGO, Calif. – April 28, 2015 – BioMed Realty Trust, Inc. (NYSE: BMR), the leading real estate company
April 29, 2015	EX-10.4	CHANGE IN CONTROL AND SEVERANCE AGREEMENT EXHIBIT 10.4 CHANGE IN CONTROL AND SEVERANCE AGREEMENT THIS CHANGE IN CONTROL AND SEVERANCE AGREEMENT (this ?Agreement?), effective as of August 28, 2013 (the ?Effective Date?), is entered into by and among BioMed Realty Trust, Inc., a Maryland corporation (the ?REIT?), BioMed Realty, L.P., a Maryland limited partnership (the ?Operating Partnership,? and together with the REIT, the ?Company?), and
April 29, 2015	EX-10.5	BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. ANNUAL INCENTIVE BONUS PLAN EXHIBIT 10.5 BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. ANNUAL INCENTIVE BONUS PLAN This Annual Incentive Bonus Plan (the ?Plan?) is intended to provide an additional incentive for employees of BioMed Realty Trust, Inc. (the ?REIT?), a Maryland corporation, and BioMed Realty, L.P. (the ?Partnership?), a Maryland limited partnership, and their subsidiaries (collectively, the ?Company?), to furth
April 29, 2015	EX-10.1	CHANGE IN CONTROL AND SEVERANCE AGREEMENT EX-10.1 2 exhibit101.htm EXHIBIT 10.1 EXHIBIT 10.1 CHANGE IN CONTROL AND SEVERANCE AGREEMENT THIS CHANGE IN CONTROL AND SEVERANCE AGREEMENT (this “Agreement”), effective as of April 10, 2015 (the “Effective Date”), is entered into by and among BioMed Realty Trust, Inc., a Maryland corporation (the “REIT”), BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership,” and togeth
April 29, 2015	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA MARCH 31, 2015 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communi EX-99.2 Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA MARCH 31, 2015 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS MARCH 31, 2015 Page Page First Quarter Highlights 3 De
April 15, 2015	DEF 14A	Biomed Realty Trust DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.
April 15, 2015	DEFA14A	Biomed Realty Trust DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? De
February 25, 2015	424B7	95,108 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 18 (To Prospectus dated August 31, 2012) 95,108 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 18 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time to
February 25, 2015	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2015 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089
February 25, 2015	EX-10.1	EMPLOYMENT TRANSITION AND CONSULTING AGREEMENT EX-10.1 2 d880826dex101.htm EX-10.1 Exhibit 10.1 EMPLOYMENT TRANSITION AND CONSULTING AGREEMENT This Employment Transition and Consulting Agreement (this “Agreement”), effective as of the Effective Date (as defined below), is entered into by and among BioMed Realty Trust, Inc., a Maryland corporation (the “REIT”), BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership,” an
February 25, 2015	EX-99.1	[BioMed Realty Trust, Inc.] EX-99.1 Exhibit 99.1 [BioMed Realty Trust, Inc.] CONTACT: Jim Cullinan Vice President, Marketing (858) 753-8661 [email protected] BIOMED REALTY ANNOUNCES REALIGNMENT TO LEVERAGE DEPTH OF LIFE SCIENCE REAL ESTATE EXPERTISE AND INCREASE SHAREHOLDER VALUE As Part of Realignment, Company Announces Departure of Kent Griffin, President & Chief Operating Officer SAN DIEGO, CA – February 25,
February 19, 2015	424B7	148,711 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424(b)(7) Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 17 (To Prospectus dated August 31, 2012) 148,711 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 17 supplements and amends the prospectus dated August 31, 2012, relating to the resale from ti
February 11, 2015	SC 13G/A	BMR / Biomed Realty Trust / VANGUARD GROUP INC Passive Investment SC 13G/A 1 biomedrealtytrustinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11 )* Name of issuer: BioMed Realty Trust Inc Title of Class of Securities: REIT CUSIP Number: 09063H107 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box to designate the rule pursuant
February 6, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission File Number: 1-32261 (BioMed UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in its chart
February 6, 2015	EX-21.1	Name Jurisdiction of Formation/ Incorporation BioMed Realty, L.P. Maryland EXHIBIT 21.1 SUBSIDIARIES OF BIOMED REALTY TRUST, INC. AS OF DECEMBER 31, 2014: Name Jurisdiction of Formation/ Incorporation BioMed Realty, L.P. Maryland The list above excludes consolidated wholly-owned subsidiaries carrying on the same line of business (the ownership and operation of commercial real estate). A total of 180 wholly-owned subsidiaries have been excluded, 176 of which operate in th
February 6, 2015	EX-12.1	BioMed Realty Trust, Inc. Statement of Computation of Ratios Year Ended December 31, 2014 2013 2012 2011 2010 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 200,72 Exhibit 12.1 BioMed Realty Trust, Inc. Statement of Computation of Ratios Year Ended December 31, 2014 2013 2012 2011 2010 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 200,723 $ 48,114 $ 17,522 $ 44,729 $ 39,256 Amortization of interest capitalized 5,661 5,343 5,173 4,613 4,456 Distributions from unconsolidate
February 6, 2015	424B7	39,656 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 Form 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 16 (To Prospectus dated August 31, 2012) 39,656 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 16 supplements and amends the prospectus dated August 31, 2012, relating to the resale from ti
February 6, 2015	SC 13G/A	BMR / Biomed Realty Trust / VANGUARD SPECIALIZED FUNDS Passive Investment biomedrealtytrustinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:5 )* Name of issuer: BioMed Realty Trust Inc Title of Class of Securities: REIT CUSIP Number: 09063H107 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box
February 5, 2015	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA DECEMBER 31, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Comm EX-99.2 Exhibit 99.2 Revised as of 2/05/2015 SUPPLEMENTAL OPERATING AND FINANCIAL DATA DECEMBER 31, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS DECEMBER 31, 2014 Page Page
February 5, 2015	8-K/A	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2015 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (C
February 5, 2015	EX-99.1	[BioMed Realty Trust, Inc. logo] BIOMED REALTY TRUST REPORTS FOURTH QUARTER AND FULL-YEAR 2014 FINANCIAL RESULTS New Full-Year Leasing Record of 2.8 Million SF and New Strategic Investments Driving Increased FFO Guidance for 2015 EX-99.1 Exhibit 99.1 [BioMed Realty Trust, Inc. logo] CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS FOURTH QUARTER AND FULL-YEAR 2014 FINANCIAL RESULTS New Full-Year Leasing Record of 2.8 Million SF and New Strategic Investments Driving Increased FFO Guidance for 2015 SAN DIEGO, Calif. – February 4, 2015 – BioMed
February 5, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2015 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commi
February 5, 2015	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA DECEMBER 31, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Comm EX-99.2 Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA DECEMBER 31, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS DECEMBER 31, 2014 Page Page Fourth Quarter Highligh
January 23, 2015	424B7	1,064,044 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 14 (To Prospectus dated August 31, 2012) 1,064,044 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 14 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time
January 23, 2015	424B7	330,469 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424(b)(7) Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 15 (To Prospectus dated August 31, 2012) 330,469 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 15 supplements and amends the prospectus dated August 31, 2012, relating to the resale from ti
January 23, 2015	8-K	Unregistered Sales of Equity Securities Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2015 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (
January 21, 2015	424B7	402,180 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 13 (To Prospectus dated August 31, 2012) 402,180 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 13 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time t
January 16, 2015	SC TO-I/A	BMR / Biomed Realty Trust SC TO-I/A - - SC TO-I/A SC TO-I/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO-I/A Amendment No. 2 TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 BIOMED REALTY, L.P. (Name of Subject Company (Issuer)) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Names of Filing Persons (Guarantor and Issuer)) 3.75% Exchangeable Senior Notes due 2030 (Title of Cl
January 9, 2015	424B7	3,035,686 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 12 (To Prospectus dated August 31, 2012) 3,035,686 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 12 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time
January 2, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2014 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089
January 2, 2015	EX-10.1	EMPLOYMENT TRANSITION AND CONSULTING AGREEMENT EX-10.1 Exhibit 10.1 EMPLOYMENT TRANSITION AND CONSULTING AGREEMENT This Employment Transition and Consulting Agreement (this “Agreement”), effective as of the Effective Date (as defined below), is entered into by and among BioMed Realty Trust, Inc., a Maryland corporation (the “REIT”), BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership,” and together with the REIT, th
December 30, 2014	424B7	397,157 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 11 (To Prospectus dated August 31, 2012) 397,157 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 11 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time t
December 15, 2014	EX-99.(A)(1)(B)	Request for Taxpayer Identification Number and Certification EX-99.(a)(1)(B) Exhibit (a)(1)(B) Form W-9 (Rev. August 2013) Department of the Treasury Internal Revenue Service Request for Taxpayer Identification Number and Certification Give Form to the requester. Do not send to the IRS. Print or type See Specific Instructions on page 2. Name (as shown on your income tax return) Business name/disregarded entity name, if different from above Check appropriate
December 15, 2014	EX-99.(A)(1)(A)	ISSUER REPURCHASE NOTICE TO HOLDERS OF 3.75% EXCHANGEABLE SENIOR NOTES DUE 2030 ISSUED BY BIOMED REALTY, L.P. CUSIP Number: 09064AAB7 EX-99.(a)(1)(A) Exhibit (a)(1)(A) ISSUER REPURCHASE NOTICE TO HOLDERS OF 3.75% EXCHANGEABLE SENIOR NOTES DUE 2030 ISSUED BY BIOMED REALTY, L.P. CUSIP Number: 09064AAB7 NOTICE IS HEREBY GIVEN pursuant to Section 3.06 of the Indenture, dated as of January 11, 2010 (the “Indenture”), among BioMed Realty, L.P., as Issuer (referred to as “we” or the “Company”), BioMed Realty Trust, Inc., as Guarantor (
December 15, 2014	SC TO-I/A	BMR / Biomed Realty Trust SC TO-I/A - - SC TO-I/A SC TO-I/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO-I/A Amendment No. 1 Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 BIOMED REALTY, L.P. (Name of Subject Company (issuer)) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Names of Filing Persons (guarantor and issuer)) 3.75% Exchangeable Senior Notes due 2030 (Title of Cl
December 15, 2014	EX-99.(A)(5)(A)	BIOMED REALTY ANNOUNCES REPURCHASE AT OPTION OF HOLDERS AND REDEMPTION OF 3.75% EXCHANGEABLE SENIOR NOTES DUE 2030 EX-99.(a)(5)(A) Exhibit (a)(5)(A) CONTACT: Rick Howe Senior Director, Corporate Communications (858) 207-5859 [email protected] BIOMED REALTY ANNOUNCES REPURCHASE AT OPTION OF HOLDERS AND REDEMPTION OF 3.75% EXCHANGEABLE SENIOR NOTES DUE 2030 SAN DIEGO, Calif. – December 12, 2014 – BioMed Realty Trust, Inc. (the “Company”) (NYSE: BMR) announced today that holders of the 3.75% Exchangea
December 12, 2014	8-K	Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2014 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioM
December 12, 2014	EX-99.2	NOTICE OF REDEMPTION TO HOLDERS OF 3.75% EXCHANGEABLE SENIOR NOTES DUE 2030 ISSUED BY BIOMED REALTY, L.P. CUSIP Number: 09064AAB7 EX-99.2 Exhibit 99.2 NOTICE OF REDEMPTION TO HOLDERS OF 3.75% EXCHANGEABLE SENIOR NOTES DUE 2030 ISSUED BY BIOMED REALTY, L.P. CUSIP Number: 09064AAB7 NOTICE IS HEREBY GIVEN pursuant to Section 3.02 of the Indenture, dated as of January 11, 2010 (the “Indenture”), among BioMed Realty, L.P., as issuer (the “Company”), BioMed Realty Trust, Inc., as guarantor (the “Guarantor”), and U.S. Bank National
November 4, 2014	424B7	1,097,156 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 10 (To Prospectus dated August 31, 2012) 1,097,156 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 10 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time
October 30, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 Commission File Number: 1-3226 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in
October 30, 2014	EX-99.1	[BioMed Realty Trust, Inc. Logo] BIOMED REALTY TRUST REPORTS THIRD QUARTER 2014 FINANCIAL RESULTS Positive Net Absorption Exceeds 219,000 SF; 2014 FFO Guidance Increased EX-99.1 Exhibit 99.1 [BioMed Realty Trust, Inc. Logo] CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS THIRD QUARTER 2014 FINANCIAL RESULTS Positive Net Absorption Exceeds 219,000 SF; 2014 FFO Guidance Increased SAN DIEGO, Calif. – October 29, 2014 – BioMed Realty Trust, Inc. (NYSE: BMR), the leading real estate com
October 30, 2014	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA SEPTEMBER 30, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Com EX-99.2 Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA SEPTEMBER 30, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS SEPTEMBER 30, 2014 Page Page Third Quarter Highlig
October 30, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2014 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commi
October 30, 2014	EX-10.1	SECOND AMENDMENT TO 2013 AMENDMENT AND RESTATMENT OF THE BIOMED REALTY TRUST, INC. AND BIOMED REALTY, L.P. 2004 INCENTIVE AWARD PLAN EXHIBIT 10.1 SECOND AMENDMENT TO 2013 AMENDMENT AND RESTATMENT OF THE BIOMED REALTY TRUST, INC. AND BIOMED REALTY, L.P. 2004 INCENTIVE AWARD PLAN This Second Amendment (this ?Amendment?) to the 2013 Amendment and Restatement of the BioMed Realty Trust, Inc. and BioMed Realty, L.P. 2004 Incentive Award Plan (the ?Plan?) is made as of August 27, 2014. All capitalized terms used but not defined in th
September 15, 2014	8-K	Unregistered Sales of Equity Securities FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2014 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation)
September 9, 2014	424B7	634,500 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 1 d786929d424b7.htm 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 9 (To Prospectus dated August 31, 2012) 634,500 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 9 supplements and amends the prospectus dated August 31, 2012, relating t
September 5, 2014	424B7	39,656 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 8 (To Prospectus dated August 31, 2012) 39,656 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 8 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time to t
August 6, 2014	EX-99.1	BIOMED REALTY TRUST REPORTS SECOND QUARTER 2014 FINANCIAL RESULTS Second Quarter Leasing Volume Exceeds 810,000 SF; FFO of $0.40 per Diluted Share Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS SECOND QUARTER 2014 FINANCIAL RESULTS Second Quarter Leasing Volume Exceeds 810,000 SF; FFO of $0.40 per Diluted Share SAN DIEGO, Calif. ? August 5, 2014 ? BioMed Realty Trust, Inc. (NYSE: BMR), the leading real estate company focusing on life sciences, t
August 6, 2014	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2014 BioMed Realty Trus FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2014 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Co
August 6, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 Commission File Number: 1-32261 (Bi UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in its c
August 6, 2014	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA JUNE 30, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communic EX-99.2 Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA JUNE 30, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS JUNE 30, 2014 Page Page Second Quarter Highlights 3 Com
August 4, 2014	424B7	1,454,060 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 7 (To Prospectus dated August 31, 2012) 1,454,060 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 7 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time t
August 1, 2014	8-K	Unregistered Sales of Equity Securities Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2014 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Com
July 25, 2014	424B7	1,520,157 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 6 (To Prospectus dated August 31, 2012) 1,520,157 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 6 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time t
July 23, 2014	424B7	660,938 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 5 (To Prospectus dated August 31, 2012) 660,938 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 5 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time to
July 18, 2014	424B7	1,466,555 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 Prospectus Supplement No. 4 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 4 (To Prospectus dated August 31, 2012) 1,466,555 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 4 supplements and amends the prospectus dated August 31, 2012, relating to
June 27, 2014	424B7	856,840 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 Prospectus Supplement No. 3 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 3 (To Prospectus dated August 31, 2012) 856,840 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 3 supplements and amends the prospectus dated August 31, 2012, relating to th
June 4, 2014	S-3ASR	- S-3ASR S-3ASR Table of Contents As filed with the Securities and Exchange Commission on June 4, 2014 Registration No.
May 30, 2014	8-K	Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2014 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Comm
May 19, 2014	DEFA14A	- DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ De
May 2, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 Commission File Number: 1-32261 (B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in its
May 1, 2014	EX-99.1	[BioMed Realty Trust, Inc. Logo] BIOMED REALTY TRUST REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS First Quarter Leasing Volume of 480,400 SF; Same Property Cash NOI Up 6.8% Year-over-Year EX-99.1 Exhibit 99.1 [BioMed Realty Trust, Inc. Logo] CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS First Quarter Leasing Volume of 480,400 SF; Same Property Cash NOI Up 6.8% Year-over-Year SAN DIEGO, Calif. – April 30, 2014 – BioMed Realty Trust, Inc. (NYSE: BMR), the leading
May 1, 2014	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA MARCH 31, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communi EX-99.2 Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA MARCH 31, 2014 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS MARCH 31, 2014 Page Page First Quarter Highlights 3 Co
May 1, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2014 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commiss
April 23, 2014	EX-4.2	BIOMED REALTY, L.P., BIOMED REALTY TRUST, INC., U.S. BANK NATIONAL ASSOCIATION, AS SUPPLEMENTAL INDENTURE NO. 3 DATED AS OF APRIL 23, 2014 2.625% SENIOR NOTES DUE 2019 EX-4.2 Exhibit 4.2 BIOMED REALTY, L.P., ISSUER, BIOMED REALTY TRUST, INC., GUARANTOR, AND U.S. BANK NATIONAL ASSOCIATION, AS TRUSTEE SUPPLEMENTAL INDENTURE NO. 3 DATED AS OF APRIL 23, 2014 $400,000,000 2.625% SENIOR NOTES DUE 2019 SUPPLEMENTAL INDENTURE NO. 3, dated as of April 23, 2014 (this “Third Supplemental Indenture”), among BioMed Realty, L.P., a Maryland limited partnership (the “Company”)
April 23, 2014	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2014 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (Bi
April 17, 2014	EX-1.1	BioMed Realty, L.P. (a Maryland limited partnership) As Issuer BioMed Realty Trust, Inc. (a Maryland corporation) As Guarantor 2.625% Senior Notes due 2019 Underwriting Agreement EX-1.1 Exhibit 1.1 BioMed Realty, L.P. (a Maryland limited partnership) As Issuer BioMed Realty Trust, Inc. (a Maryland corporation) As Guarantor $400,000,000 2.625% Senior Notes due 2019 Underwriting Agreement April 15, 2014 DEUTSCHE BANK SECURITIES INC. WELLS FARGO SECURITIES, LLC As Representatives of the Several Underwriters listed on Schedule I hereto c/o Deutsche Bank Securities Inc. 60 Wall
April 17, 2014	8-K	Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2014 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (Bi
April 16, 2014	424B2	CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Maximum Offering Price Per Unit Maximum Aggregate Offering Price Amount of Registration Fee BioMed Realty, L.P. 2.625% Notes due 2019 $400,000, Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Nos. 333-183669 and 333-183669-01 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Maximum Offering Price Per Unit Maximum Aggregate Offering Price Amount of Registration Fee BioMed Realty, L.P. 2.625% Notes due 2019 $400,000,000 99.408% $397,632,000 $51,215(1) BioMed Realty Tr
April 15, 2014	424B5	SUBJECT TO COMPLETION, DATED APRIL 15, 2014 424B5 Table of Contents The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed.
April 15, 2014	FWP	BioMed Realty, L.P. $400,000,000 2.625% Senior Notes due 2019 fully and unconditionally guaranteed by BioMed Realty Trust, Inc. Issuer: BioMed Realty, L.P. Guarantor: BioMed Realty Trust, Inc. Ratings: (Moody’s / S&P)* Baa3 / BBB Security Type: Senio FWP 1 d711744dfwp.htm FWP Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Registration Nos. 333-183669 and 333-183669-01 April 15, 2014 BioMed Realty, L.P. $400,000,000 2.625% Senior Notes due 2019 fully and unconditionally guaranteed by BioMed Realty Trust, Inc. Issuer: BioMed Realty, L.P. Guarantor: BioMed Realty Trust, Inc. Ratings: (Moody’s / S&P)* Baa3 / BBB Security Type: Senior Un
April 14, 2014	DEFA14A	- DEFA14A DEFA14A 1 d710404ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permi
April 14, 2014	DEF 14A	- DEF 14A DEF 14A 1 d701245ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commissi
April 9, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2014 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 20-1142292 (BioMed Realty Trust, Inc.) (Sta
April 9, 2014	EX-99.1	BIOMED REALTY TRUST APPOINTS JANICE L. SEARS, FORMER BANK OF AMERICA EXECUTIVE, TO ITS BOARD OF DIRECTORS CONTACT: Rick Howe Senior Director, Corporate Communications (858) 207 - 5859 richard.
March 25, 2014	CORRESP	- CORRESP March 25, 2014 VIA EDGAR Daniel L. Gordon Branch Chief Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: BioMed Realty Trust, Inc. BioMed Realty, L.P. Form 10-K for the Fiscal Year ended December 31, 2013 Filed February 10, 2014 File No. 001-32261 and File No. 000-54089 Dear Mr. Gordon: BioMed Realty Trust, Inc. and BioMed Real
February 11, 2014	SC 13G/A	BMR / Biomed Realty Trust / VANGUARD GROUP INC Passive Investment biomedrealtytrust.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10 )* Name of issuer: BioMed Realty Trust Inc Title of Class of Securities: REIT CUSIP Number: 09063H107 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box t
February 11, 2014	S-8	- FORM S-8 Form S-8 As filed with the Securities and Exchange Commission on February 10, 2014 Registration No.
February 10, 2014	EX-12.1	BioMed Realty Trust, Inc. Statement of Computation of Ratios Year Ended December 31, 2013 2012 2011 2010 2009 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 48,114 Exhibit 12.1 BioMed Realty Trust, Inc. Statement of Computation of Ratios Year Ended December 31, 2013 2012 2011 2010 2009 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 48,114 $ 17,522 $ 44,729 $ 39,256 $ 60,798 Amortization of interest capitalized 5,343 5,173 4,613 4,456 3,009 Distributions from unconsolidated
February 10, 2014	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 Commission File Number: 1-32261 (BioMed 10-K 1 bmr-20131231x10k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of reg
February 10, 2014	EX-10.2	AMENDMENT ONE TO THE FOURTH AMENDED AND RESTATED AGREEMENT OF LIMITED PARTNERSHIP BIOMED REALTY, L.P. EX-10.2 2 exhibit102.htm EXHIBIT AMENDMENT ONE TO THE FOURTH AMENDED AND RESTATED AGREEMENT OF LIMITED PARTNERSHIP OF BIOMED REALTY, L.P. THIS AMENDMENT ONE (this “Amendment”) TO THE FOURTH AMENDED AND RESTATED AGREEMENT OF LIMITED PARTNERSHIP (the “Current Partnership Agreement”) of BioMed Realty, L.P., a Maryland limited partnership (the “Partnership”), is executed and effective as of the 6th da
February 10, 2014	EX-21.1	Name Jurisdiction of Formation/ Incorporation BioMed Realty, L.P. Maryland EXHIBIT 21.1 SUBSIDIARIES OF BIOMED REALTY TRUST, INC. AS OF DECEMBER 31, 2013: Name Jurisdiction of Formation/ Incorporation BioMed Realty, L.P. Maryland The list above excludes consolidated wholly-owned subsidiaries carrying on the same line of business (the ownership and operation of commercial real estate). A total of 174 wholly-owned subsidiaries have been excluded, 173 of which operate in th
February 6, 2014	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA DECEMBER 31, 2013 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Comm EX-99.2 Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA DECEMBER 31, 2013 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS DECEMBER 31, 2013 Page Page Fourth Quarter Highligh
February 6, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2014 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commi
February 6, 2014	EX-99.1	[BioMed Realty Trust, Inc. Logo] BIOMED REALTY TRUST REPORTS FOURTH QUARTER AND FULL-YEAR 2013 FINANCIAL RESULTS Fourth Quarter Leasing Volume of 441,800 SF; Same Property Cash NOI Up 6.6% Year-over-Year EX-99.1 Exhibit 99.1 [BioMed Realty Trust, Inc. Logo] CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS FOURTH QUARTER AND FULL-YEAR 2013 FINANCIAL RESULTS Fourth Quarter Leasing Volume of 441,800 SF; Same Property Cash NOI Up 6.6% Year-over-Year SAN DIEGO, Calif. – February 5, 2014 – BioMed Realty Trust, Inc. (NYSE:
February 4, 2014	SC 13G/A	BMR / Biomed Realty Trust / VANGUARD SPECIALIZED FUNDS Passive Investment biomedreatlytrustinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:4)* Name of issuer: BioMed Realty Trust Inc Title of Class of Securities: REIT CUSIP Number: 09063H107 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box t
December 18, 2013	EX-99.1	BIOMED REALTY TRUST APPOINTS DR. WILLIAM R. BRODY, PRESIDENT OF THE SALK INSTITUTE, TO ITS BOARD OF DIRECTORS CONTACT: Rick Howe Senior Director, Corporate Communications (858) 207 - 5859 BIOMED REALTY TRUST APPOINTS DR.
December 18, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2013 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 20-1142292 (BioMed Realty Trust, Inc.)
November 6, 2013	EX-10.1	DIRECTOR COMPENSATION POLICY (effective as of July 1, 2013) DIRECTOR COMPENSATION POLICY (effective as of July 1, 2013) Members of the board of directors (the ?Board?) of BioMed Realty Trust, Inc.
November 6, 2013	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA SEPTEMBER 30, 2013 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Com EX-99.2 Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA SEPTEMBER 30, 2013 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS SEPTEMBER 30, 2013 Page Page Third Quarter Highlig
November 6, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 Commission File Number: 1-3226 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in
November 6, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2013 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commi
November 6, 2013	EX-99.1	[BioMed Realty Trust, Inc. Logo] BIOMED REALTY TRUST REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS Wexford Operating Properties Achieve Early Stabilization; Same Property Cash NOI Increases 5.7%, Year-over-Year EX-99.1 Exhibit 99.1 [BioMed Realty Trust, Inc. Logo] CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS Wexford Operating Properties Achieve Early Stabilization; Same Property Cash NOI Increases 5.7%, Year-over-Year SAN DIEGO, Calif. – November 5, 2013 – BioMed Realty Trust, Inc.
September 30, 2013	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2013 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 20-1142292 (BioMed
September 30, 2013	EX-10.4	TERM NOTE TERM NOTE September , 2013 FOR VALUE RECEIVED, BIOMED REALTY, L.P., a Maryland limited partnership, (“Borrower”), promises to pay to the order of (“Bank”) the aggregate principal amount of all Term Advances (as such term is defined in the Credit Agreement) as has been borrowed by the Borrower from Bank under the Credit Agreement hereinafter described, or such lesser aggregate amount of the Term Ad
September 30, 2013	EX-99.1	BIOMED REALTY INCREASES CAPACITY UNDER CREDIT FACILITY TO $1.25 BILLION CONTACT: Rick Howe Senior Director, Corporate Communications (858) 207 - 5859 BIOMED REALTY INCREASES CAPACITY UNDER CREDIT FACILITY TO $1.
September 30, 2013	EX-10.3	[AMENDED AND RESTATED] COMPETITIVE BID NOTE [AMENDED AND RESTATED] COMPETITIVE BID NOTE September , 2013 FOR VALUE RECEIVED, BIOMED REALTY, L.
September 30, 2013	EX-10.2	[AMENDED AND RESTATED] LINE NOTE EX-10.2 3 exhibit102.htm EX-10.2 [AMENDED AND RESTATED] LINE NOTE , 2013 FOR VALUE RECEIVED, BIOMED REALTY, L.P., a Maryland limited partnership (“Borrower”), promises to pay to the order of (“Bank”) the aggregate principal amount of all Line Advances (as such term is defined in the Credit Agreement) as has been borrowed by the Borrower from Bank under the Credit Agreement hereinafter described, o
September 30, 2013	EX-10.1	AMENDED AND RESTATED UNSECURED CREDIT AGREEMENT DATED AS OF SEPTEMBER 24, 2013 BIOMED REALTY, L.P., AS BORROWER KEYBANK NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT AND CO-LEAD ARRANGER WELLS FARGO BANK NATIONAL ASSOCIATION, AS SYNDICATION AGENT WEL EX-10.1 2 exhibit101.htm EX-10.1 EXECUTION COPY AMENDED AND RESTATED UNSECURED CREDIT AGREEMENT DATED AS OF SEPTEMBER 24, 2013 AMONG BIOMED REALTY, L.P., AS BORROWER AND KEYBANK NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT AND CO-LEAD ARRANGER AND WELLS FARGO BANK NATIONAL ASSOCIATION, AS SYNDICATION AGENT AND WELLS FARGO SECURITIES, LLC AS CO-LEAD ARRANGER AND U.S. BANK NATIONAL ASSOCIATION, AS
September 30, 2013	EX-10.5	AMENDED AND RESTATED SWING LOAN NOTE AMENDED AND RESTATED SWING LOAN NOTE September 24, 2013 FOR VALUE RECEIVED, BIOMED REALTY, L.
September 30, 2013	EX-10.6	SECOND AMENDMENT TO UNSECURED TERM CREDIT AGREEMENT EXECUTION COPY SECOND AMENDMENT TO UNSECURED TERM CREDIT AGREEMENT This Second Amendment to Unsecured Term Credit Agreement (this “Amendment”) is made as of September 24, 2013 (the “Amendment Effective Date”), by and among BIOMED REALTY, L.
September 6, 2013	EX-3.1	BIOMED REALTY TRUST, INC. THIRD AMENDED AND RESTATED BYLAWS ARTICLE I BIOMED REALTY TRUST, INC. THIRD AMENDED AND RESTATED BYLAWS ARTICLE I OFFICES Section 1. PRINCIPAL OFFICE. The principal office of the Corporation in the State of Maryland shall be located at such place as the Board of Directors may designate. Section 2. ADDITIONAL OFFICES. The Corporation may have additional offices, including a principal executive office, at such places as the Board of Directors
September 6, 2013	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2013 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 20-1142292 (BioMed Realty Trust, Inc.)
August 15, 2013	8-K/A	Financial Statements and Exhibits - FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A Amendment No. 1 to CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2013 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000
August 14, 2013	424B7	660,938 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 1 d584473d424b7.htm PROSPECTUS SUPPLEMENT NO. 2 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 2 (To Prospectus dated August 31, 2012) 660,938 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 2 supplements and amends the prospectus dated Augus
August 7, 2013	EX-3.1	BIOMED REALTY, L.P. CERTIFICATE OF AMENDMENT BIOMED REALTY, L.P. CERTIFICATE OF AMENDMENT BioMed Realty, L.P., a Maryland limited partnership (the ?Partnership?), does hereby certify that: FIRST: The name of the Partnership is BioMed Realty, L.P. SECOND: Article FOURTH of the Certificate of Limited Partnership of the Partnership is hereby deleted in its entirety and the following is inserted in lieu thereof: ?FOURTH: The name and address of
August 7, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2013 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (Bi
August 7, 2013	EX-99.1	[BioMed Realty Trust, Inc. Logo] BIOMED REALTY TRUST REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS Second Quarter Leasing Volume of 898,000 Square Feet – Largest in Company History EX-99.1 Exhibit 99.1 [BioMed Realty Trust, Inc. Logo] CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS Second Quarter Leasing Volume of 898,000 Square Feet – Largest in Company History SAN DIEGO, Calif. – August 6, 2013 – BioMed Realty Trust, Inc. (NYSE: BMR), a real estate inve
August 7, 2013	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA JUNE 30, 2013 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communic Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA JUNE 30, 2013 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS JUNE 30, 2013 Page Page Second Quarter Highlights 3 Common and
August 7, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 Commission File Number: 1-32261 (Bi 10-Q 1 bmr-2013630x10q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of
August 2, 2013	424B7	CALCULATION OF REGISTRATION FEE Title of Securities Being Registered Amount to be Registered Maximum Offering Price Per Share(1) Maximum Aggregate Offering Price(1) Amount of Registration Fee(1) Common Stock, $0.01 par value per share 5,548,158 $ 20. 424B7 1 d573757d424b7.htm PROSPECTUS SUPPLEMENT Table of Contents Filed Pursuant to Rule 424(b)(7) Registration Statement No. 333-183669 PROSPECTUS SUPPLEMENT (To Prospectus dated August 31, 2012) CALCULATION OF REGISTRATION FEE Title of Securities Being Registered Amount to be Registered Maximum Offering Price Per Share(1) Maximum Aggregate Offering Price(1) Amount of Registration Fee(1) Common S
June 20, 2013	8-K	Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2013 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 20-1142292 (BioMed Real
June 3, 2013	EX-99.1	BioMed Realty Expands Footprint in University/Research Markets with 1.6 Million Square Feet of High-Quality Assets and 935,000 Square Feet of Development Projects CONTACT: Rick Howe Senior Director, Corporate Communications (858) 207 - 5859 BIOMED REALTY AND WEXFORD SCIENCE & TECHNOLOGY COMPLETE MERGER BioMed Realty Expands Footprint in University/Research Markets with 1.
June 3, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2013 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 20-1142292 (BioMed Realt
June 3, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2013 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 20-1142292 (BioMed Realt
June 3, 2013	EX-10.2	FIRST AMENDMENT TO THE 2013 AMENDMENT AND RESTATEMENT OF THE BIOMED REALTY TRUST, INC. AND BIOMED REALTY, L.P. 2004 INCENTIVE AWARD PLAN FIRST AMENDMENT TO THE 2013 AMENDMENT AND RESTATEMENT OF THE BIOMED REALTY TRUST, INC.
June 3, 2013	EX-10.1	2013 AMENDMENT AND RESTATEMENT OF THE BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. 2004 INCENTIVE AWARD PLAN ARTICLE 1 2013 AMENDMENT AND RESTATEMENT OF THE BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. 2004 INCENTIVE AWARD PLAN ARTICLE 1 PURPOSE The purpose of the BioMed Realty Trust, Inc. and BioMed Realty, L.P. 2004 Incentive Award Plan (the “Plan”) is to promote the success and enhance the value of BioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited pa
May 23, 2013	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive
May 20, 2013	DEFA14A	- DEFINITIVE ADDITIONAL MATERIALS DEFA14A 1 d541760ddefa14a.htm DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the C
May 2, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 Commission File Number: 1-32261 (B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in its
May 2, 2013	EX-99.1	BIOMED REALTY TRUST REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS First Quarter Leasing Volume of 583,700 Square Feet EX-99.1 Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS First Quarter Leasing Volume of 583,700 Square Feet SAN DIEGO, Calif. – May 1, 2013 – BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust (REIT) that delivers optimal real estate solutions for
May 2, 2013	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA MARCH 31, 2013 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communi Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA MARCH 31, 2013 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONTENTS MARCH 31, 2013 Page Page First Quarter Highlights 3 Common and
May 2, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2013 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commission Fil
April 18, 2013	DEFA14A	- SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive
April 18, 2013	DEF 14A	- DEFINITIVE PROXY STATEMENT DEF 14A 1 d520899ddef14a.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commiss
April 17, 2013	424B7	561,797 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 424B7 Filed pursuant to Rule 424(b)(7) SEC File No. 333-183676 PROSPECTUS SUPPLEMENT NO. 1 (To Prospectus dated August 31, 2012) 561,797 Shares BioMed Realty Trust, Inc. Common Stock Issuable upon Exchange of BioMed Realty, L.P. 3.75% Exchangeable Senior Notes due 2030 This prospectus supplement no. 1 supplements and amends the prospectus dated August 31, 2012, relating to the resale from time to
April 2, 2013	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2013 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commission
April 2, 2013	EX-1.1	15,000,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland corporation) Underwriting Agreement 15,000,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland corporation) Underwriting Agreement March 27, 2013 Morgan Stanley & Co. LLC Raymond James & Associates, Inc. As Representatives of the Several Underwriters listed on Schedule I hereto c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Ladies and Gentlemen: BioMed Realty Trust, Inc.,
March 27, 2013	424B5	CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee Common Stock, $0.01 par value per 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Statement No.
March 26, 2013	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2013 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (Bi
March 26, 2013	424B5	15,000,000 Shares COMMON STOCK 424B5 Table of Contents The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed.
March 26, 2013	EX-2.1	AGREEMENT AND PLAN OF MERGER BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. WESTCO SUB LLC WEXFORD SCIENCE & TECHNOLOGY, LLC WEXFORD EQUITIES, LLC dated as of March 26, 2013 TABLE OF CONTENTS PAGE ARTICLE I DEFINITIONS 7 ARTICLE II THE MERGER 22 Secti EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. WESTCO SUB LLC WEXFORD SCIENCE & TECHNOLOGY, LLC and WEXFORD EQUITIES, LLC dated as of March 26, 2013 TABLE OF CONTENTS PAGE ARTICLE I DEFINITIONS 7 ARTICLE II THE MERGER 22 Section 2.01 The Merger 22 Section 2.02 Effective Time 22 Section 2.03 Effect of the Merger 22 Section 2.04 Articles of Organi
March 26, 2013	EX-99.1	[BioMed Realty Trust, Inc. Logo] WEXFORD SCIENCE & TECHNOLOGY TO MERGE WITH BIOMED REALTY TRUST BioMed Realty Adds 1.6 Million Square Foot Portfolio & Expands University / Research Institution Segment to 18% of Annualized Base Rents EX-99.1 Exhibit 99.1 [BioMed Realty Trust, Inc. Logo] CONTACT: Rick Howe Senior Director, Corporate Communications (858) 207 – 5859 WEXFORD SCIENCE & TECHNOLOGY TO MERGE WITH BIOMED REALTY TRUST BioMed Realty Adds 1.6 Million Square Foot Portfolio & Expands University / Research Institution Segment to 18% of Annualized Base Rents SAN DIEGO, California and BALTIMORE, Maryland. – March 26, 2013 – Bi
March 20, 2013	EX-99.25	EX-99.25 NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on April 1, 2013, pursuant to the provisions of Rule 12d2-2 (a).
February 19, 2013	8-K	Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2013 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commissi
February 19, 2013	EX-1.1	12,700,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland corporation) Underwriting Agreement 12,700,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland corporation) Underwriting Agreement February 13, 2013 MORGAN STANLEY & CO. LLC RAYMOND JAMES & ASSOCIATES, INC. As Representatives of the Several Underwriters listed on Schedule I hereto c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Ladies and Gentlemen: BioMed Realty Trust, In
February 14, 2013	SC 13G/A	BMR / Biomed Realty Trust / VANGUARD SPECIALIZED FUNDS Passive Investment SC 13G/A 1 biomedrealtytrustinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:3 )* Name of issuer: BioMed Realty Trust Inc Title of Class of Securities: REIT CUSIP Number: 09063H107 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to designate the rule pursuant to
February 13, 2013	424B5	CALCULATION OF REGISTRATION FEE Title of each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee Common Stock, $0.01 par value per Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Statement No. 333-183669 CALCULATION OF REGISTRATION FEE Title of each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee Common Stock, $0.01 par value per share $14,605,000 $20.50 $299,402,500 $40,839(1) (1) Calcula
February 12, 2013	EX-3.1	BIOMED REALTY TRUST, INC. ARTICLES OF AMENDMENT EX-3.1 Exhibit 3.1 BIOMED REALTY TRUST, INC. ARTICLES OF AMENDMENT BioMed Realty Trust, Inc., a Maryland corporation (the “Corporation”), hereby certifies to the State Department of Assessments and Taxation of Maryland that: FIRST: The charter of the Corporation (the “Charter”) is hereby amended by deleting therefrom in its entirety the first two sentences of Section 5.1 of Article V and inserting
February 12, 2013	424B5	11,500,000 Shares COMMON STOCK 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Statement Nos.
February 12, 2013	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2013 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed R
February 11, 2013	SC 13G/A	BMR / Biomed Realty Trust / VANGUARD GROUP INC Passive Investment biomedrealtytrustinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9 )* Name of issuer: BioMed Realty Trust Inc Title of Class of Securities: REIT CUSIP Number: 09063H107 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box
February 6, 2013	EX-21.1	Name Jurisdiction of Formation/ Incorporation BioMed Realty, L.P. Maryland EXHIBIT 21.1 SUBSIDIARIES OF BIOMED REALTY TRUST, INC. AS OF DECEMBER 31, 2012: Name Jurisdiction of Formation/ Incorporation BioMed Realty, L.P. Maryland The list above excludes consolidated wholly-owned subsidiaries carrying on the same line of business (the ownership and operation of commercial real estate). A total of 110 wholly-owned subsidiaries have been excluded, 109 of which operate in th
February 6, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2013 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (Commissio
February 6, 2013	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission File Number: 1-32261 (BioMed UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in its chart
February 6, 2013	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA DECEMBER 31, 2012 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Comm BIOMED REALTY TRUST, INC. SUPPLEMENTAL OPERATING AND FINANCIAL DATA Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA DECEMBER 31, 2012 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF
February 6, 2013	EX-12.1	BioMed Realty Trust, Inc. Statement of Computation of Ratios Year Ended December 31, 2012 2011 2010 2009 2008 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 17,522 Exhibit 12.1 BioMed Realty Trust, Inc. Statement of Computation of Ratios Year Ended December 31, 2012 2011 2010 2009 2008 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 17,522 $ 44,729 $ 39,256 $ 60,798 $ 62,563 Amortization of interest capitalized 5,173 4,613 4,456 3,009 1,308 Distributions from unconsolidated
February 6, 2013	EX-99.1	BIOMED REALTY TRUST REPORTS FOURTH QUARTER AND FULL-YEAR 2012 FINANCIAL RESULTS Fourth Quarter Leasing Volume of 624,900 Square Feet; Fourth Quarter FFO and AFFO per Share Up 20.0% and 17.9% Over 2011, Respectively PRESS RELEASE ISSUED BY BIOMED REALTY TRUST, INC. Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS FOURTH QUARTER AND FULL-YEAR 2012 FINANCIAL RESULTS Fourth Quarter Leasing Volume of 624,900 Square Feet; Fourth Quarter FFO and AFFO per Share Up 20.0% and 17.9% Over 2011, Respectively SAN DIEGO, Calif.
January 30, 2013	SC 13G/A	BMR / Biomed Realty Trust / VANGUARD SPECIALIZED FUNDS Passive Investment biomedrealtytrust2.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:2)* Name of issuer: BioMed Realty Trust Inc Title of Class of Securities: REIT CUSIP Number: 09063H107 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to
January 4, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2013 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (C
January 4, 2013	EX-99.1	[BioMed Realty Trust, Inc. Logo] Exhibit 99.1 [BioMed Realty Trust, Inc. Logo] CONTACT: Rick Howe Senior Director, Corporate Communications (858) 207 – 5859 BIOMED REALTY TRUST APPOINTS FORMER AMYLIN PRESIDENT AND CHIEF EXECUTIVE OFFICER TO ITS BOARD OF DIRECTORS SAN DIEGO, Calif. – January 4, 2013 – BioMed Realty Trust, Inc. (NYSE: BMR) today announced the appointment of Daniel M. Bradbury to its board of directors, increasing t
November 2, 2012	8-K	Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2012 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Re
November 2, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2012 BioMed Realty Trust, Inc. (Exact name of registrant as specified in its charter) Maryland 1-32261 20-1142292 (State or Other Jurisdiction of Incorporation) (
November 2, 2012	EX-10.1	SECOND AMENDMENT TO 2009 AMENDMENT AND RESTATMENT OF THE BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. 2004 INCENTIVE AWARD PLAN EX-10.1 2 exhibit101.htm EXHIBIT 10.1 SECOND AMENDMENT TO 2009 AMENDMENT AND RESTATMENT OF THE BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. 2004 INCENTIVE AWARD PLAN This Second Amendment (this “Amendment”) to the 2009 Amendment and Restatement of the BioMed Realty Trust, Inc. and BioMed Realty, L.P. 2004 Incentive Award Plan (the “Plan”) is made as of August 31, 2012. All capitalized terms used
November 2, 2012	EX-10.2	DIRECTOR COMPENSATION POLICY (effective as of July 1, 2012) DIRECTOR COMPENSATION POLICY (effective as of July 1, 2012) Members of the board of directors (the ?Board?) of BioMed Realty Trust, Inc.
November 2, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 Commission File Number: 1-3226 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in
November 2, 2012	EX-99.1	[BioMed Realty Trust, Inc. Logo] BIOMED REALTY TRUST REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS Year-over-year FFO and AFFO per share rise 13.3% and 10.0%, respectively Press Release Issued by BioMed Realty Trust, Inc. Exhibit 99.1 [BioMed Realty Trust, Inc. Logo] CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS Year-over-year FFO and AFFO per share rise 13.3% and 10.0%, respectively SAN DIEGO, Calif. – November 1, 2012 – BioMed Realty Trust, In
November 2, 2012	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA BioMed Realty Trust, Inc. Supplemental Operating and Financial Data Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA SEPTEMBER 30, 2012 BioMed Realty Trust, Inc. 17190 Bernardo Center Drive San Diego, CA 92128 Corporate Communications Contact Rick Howe Senior Director, Corporate Communications [email protected] www.biomedrealty.com (858) 485-9840 phone (858) 485-9843 fax TABLE OF
August 31, 2012	S-3ASR	- FORM S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 31, 2012 Registration No.
August 31, 2012	S-3ASR	- FORM S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 31, 2012 Registration No.
August 31, 2012	EX-1.2	BIOMED REALTY TRUST, INC. Shares of Common Stock (par value $0.01 per share) AMENDED AND RESTATED EQUITY DISTRIBUTION AGREEMENT Amended and Restated Equity Distribution Agreement Exhibit 1.2 BIOMED REALTY TRUST, INC. $120,000,000 Shares of Common Stock (par value $0.01 per share) AMENDED AND RESTATED EQUITY DISTRIBUTION AGREEMENT Dated: August 31, 2012 Table of Contents Page SECTION 1. Description of Securities. 1 SECTION 2. Placements. 3 SECTION 3. Sale of Placement Securities by the Manager. 3 SECTION 4. Suspension of Sa
August 31, 2012	EX-1.3	BIOMED REALTY TRUST, INC. Shares of Common Stock (par value $0.01 per share) AMENDED AND RESTATED EQUITY DISTRIBUTION AGREEMENT Amended and Restated Equity Distribution Agreement Exhibit 1.3 BIOMED REALTY TRUST, INC. $120,000,000 Shares of Common Stock (par value $0.01 per share) AMENDED AND RESTATED EQUITY DISTRIBUTION AGREEMENT Dated: August 31, 2012 Table of Contents Page SECTION 1. Description of Securities. 1 SECTION 2. Placements. 3 SECTION 3. Sale of Placement Securities by the Manager. 3 SECTION 4. Suspension of Sa
August 31, 2012	EX-12.1	BioMed Realty Trust, Inc. Statement of Computation of Ratios 6 Mo. Ended June 30, Year Ended December 31, 2012 2011 2010 2009 2008 2007 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidat Calculation of Ratios Exhibit 12.1 BioMed Realty Trust, Inc. Statement of Computation of Ratios 6 Mo. Ended June 30, Year Ended December 31, 2012 2011 2010 2009 2008 2007 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 2,088 $ 44,729 $ 39,256 $ 60,798 $ 62,563 $ 72,528 Amortization of interest capitalized 2,560 4
August 31, 2012	S-3ASR	- FORM S-3ASR Form S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 31, 2012 Registration No.
August 31, 2012	424B5	CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Proposed Maximum Aggregate Offering Price(1) Amount of Registration Fee(2) Common Stock, $0.01 par value per share $120,000,000 — Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Statement No. 333-183669 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Proposed Maximum Aggregate Offering Price(1) Amount of Registration Fee(2) Common Stock, $0.01 par value per share $120,000,000 — (1) Amount includes shares of common stock having an aggregate offering price of up to $120,000,00
August 31, 2012	EX-1.1	BIOMED REALTY TRUST, INC. Shares of Common Stock (par value $0.01 per share) AMENDED AND RESTATED EQUITY DISTRIBUTION AGREEMENT Amended and Restated Equity Distribution Agreement Exhibit 1.1 BIOMED REALTY TRUST, INC. $120,000,000 Shares of Common Stock (par value $0.01 per share) AMENDED AND RESTATED EQUITY DISTRIBUTION AGREEMENT Dated: August 31, 2012 Table of Contents Page SECTION 1. Description of Securities. 1 SECTION 2. Placements. 3 SECTION 3. Sale of Placement Securities by the Manager. 3 SECTION 4. Suspension of Sa
August 31, 2012	8-K	Financial Statements and Exhibits, Other Events 8-K 1 d404528d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2012 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trus
August 31, 2012	S-3ASR	- FORM S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 31, 2012 Registration No.
August 24, 2012	EX-12.1	BioMed Realty Trust, Inc. Statement of Computation of Ratios Year Ended December 31, 2011 2010 2009 2008 2007 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 44,729 Exhibit 12.1 BioMed Realty Trust, Inc. Statement of Computation of Ratios Year Ended December 31, 2011 2010 2009 2008 2007 Earnings: Add: Income from continuing operations before noncontrolling interests and income/loss from unconsolidated joint ventures $ 44,729 $ 39,256 $ 60,798 $ 62,563 $ 72,528 Amortization of interest capitalized 4,613 4,456 3,009 1,308 112 Distributions from unconsolidated j
August 24, 2012	EX-99.1	PART II Exhibit 99.1 PART II ITEM 6. SELECTED FINANCIAL DATA The following tables set forth selected consolidated financial and operating data on an historical basis for BioMed Realty Trust, Inc. and BioMed Realty, L.P. The following data should be read in conjunction with our financial statements and notes thereto and “Management's Discussion and Analysis of Financial Condition and Results of Operations”
August 24, 2012	8-K	Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2012 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 20-1142292 (BioMed Re
August 2, 2012	EX-10.4	SECOND AMENDMENT TO UNSECURED CREDIT AGREEMENT Second Amendment to Unsecured Credit Agreement Exhibit 10.4 SECOND AMENDMENT TO UNSECURED CREDIT AGREEMENT This Second Amendment to Unsecured Credit Agreement (the “Amendment”) is made as of August 2, 2012 (the “Effective Date”), by and among BIOMED REALTY, L.P., a Maryland limited partnership (“Borrower”), KEYBANK NATIONAL ASSOCIATION, as “Administrative Agent,” and such of the lenders (“Lenders”
August 2, 2012	EX-10.1	FIRST AMENDMENT TO UNSECURED TERM CREDIT AGREEMENT EX-10.1 2 d390727dex101.htm FIRST AMENDMENT TO UNSECURED TERM CREDIT AGREEMENT Exhibit 10.1 FIRST AMENDMENT TO UNSECURED TERM CREDIT AGREEMENT This First Amendment to Unsecured Term Credit Agreement (the “Amendment”) is made as of August 2, 2012 (the “Amendment Effective Date”), by and among BIOMED REALTY, L.P., a Maryland limited partnership (“Borrower”), KEYBANK NATIONAL ASSOCIATION, as “Adminis
August 2, 2012	EX-99.1	BIOMED REALTY TRUST CONVERTS $156.4 MILLION OF ITS SENIOR UNSECURED TERM LOAN TO 100 MILLION POUNDS STERLING Press release Exhibit 99.1 CONTACT: Rick Howe Senior Director, Corporate Communications (858) 207-5859 [email protected] BIOMED REALTY TRUST CONVERTS $156.4 MILLION OF ITS SENIOR UNSECURED TERM LOAN TO 100 MILLION POUNDS STERLING SAN DIEGO, Calif. – August 2, 2012 – BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has closed on an amendment to its senior unsecured
August 2, 2012	EX-99.2	SUPPLEMENTAL OPERATING AND FINANCIAL DATA JUNE 30, 2012 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communic BioMed Realty Trust, Inc. Supplemental Operating and Financial Data Exhibit 99.2 SUPPLEMENTAL OPERATING AND FINANCIAL DATA JUNE 30, 2012 BioMed Realty Trust, Inc. Corporate Communications Contact www.biomedrealty.com 17190 Bernardo Center Drive Rick Howe (858) 485-9840 phone San Diego, CA 92128 Senior Director, Corporate Communications (858) 485-9843 fax [email protected] TABLE OF CONT
August 2, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2012 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Real
August 2, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 Commission File Number: 1-32261 (Bi UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 Commission File Number: 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (BioMed Realty, L.P.) BIOMED REALTY TRUST, INC. BIOMED REALTY, L.P. (Exact name of registrant as specified in its c
August 2, 2012	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2012 BioMed Realty Trust, Inc. BioMed Realty, L.P. (Exact name of registrant as specified in its charter) Maryland 1-32261 (BioMed Realty Trust, Inc.) 000-54089 (Bi
August 2, 2012	EX-10.3	FORM OF TERM NOTE (QUALIFIED FOREIGN CURRENCY) £ August 2, 2012 Form of Term Note Exhibit 10.3 FORM OF TERM NOTE (QUALIFIED FOREIGN CURRENCY) £ August 2, 2012 FOR VALUE RECEIVED, BIOMED REALTY, L.P., a Maryland limited partnership (“Borrower”), promises to pay to the order of (“Bank”) the principal amount of AND NO/100 POUNDS STERLING £( ), or such lesser aggregate amount of Foreign Currency Advances as may be made and outstanding pursuant to Bank’s Foreign Cu
August 2, 2012	EX-10.2	FORM OF AMENDED AND RESTATED TERM NOTE (DOMESTIC CURRENCY) $ August 2, 2012 Form of Amended and Restated Term Note Exhibit 10.2 FORM OF AMENDED AND RESTATED TERM NOTE (DOMESTIC CURRENCY) $ August 2, 2012 FOR VALUE RECEIVED, BIOMED REALTY, L.P., a Maryland limited partnership (“Borrower”), promises to pay to the order of (“Bank”) the principal amount of AND NO/100 DOLLARS ($ ), or such lesser aggregate amount of Domestic Currency Advances as may be made and outstanding pur
August 2, 2012	EX-99.1	[BioMed Realty Trust, Inc. Logo] BIOMED REALTY TRUST REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS Core FFO per share climbs 10.3% year-over-year to $0.32 per diluted share Exhibit 99.1 [BioMed Realty Trust, Inc. Logo] CONTACT: Rick Howe Senior Director, Corporate Communications 858.207.5859 [email protected] BIOMED REALTY TRUST REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS Core FFO per share climbs 10.3% year-over-year to $0.32 per diluted share SAN DIEGO, Calif. – August 1, 2012 – BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust foc

BMR / Beamr Imaging Ltd. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)

Other Listings